Cas:28282-27-1 3-hydroxytirucallic acid manufacturer & supplier

We serve Chemical Name:3-hydroxytirucallic acid CAS:28282-27-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-hydroxytirucallic acid

Chemical Name:3-hydroxytirucallic acid
CAS.NO:28282-27-1
Synonyms:3α-hydroxytirucalla-8,24-dien-21-oic acid;3-α-hydroxy-8,24-dienetirucallic acid;(S)-2-((3R,5R,10S,13S,14S,17S)-3-Hydroxy-4,4,10,13,14-pentamethyl-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-6-methyl-hept-5-enoic acid;α-elemolic acid;3α-hydroxytirucallic acid;3-hydroxytirucall-8,24-dien-21-oic acid;3-α-hydroxy-8,24-dientirucallic acid
Molecular Formula:C30H48O3
Molecular Weight:456.70000
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:57.53000
Exact Mass:456.36000
LogP:7.54380

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 3α-hydroxytirucalla-8,24-dien-21-oic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-α-hydroxy-8,24-dientirucallic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3α-hydroxytirucallic acid Use and application,3-α-hydroxy-8,24-dientirucallic acid technical grade,usp/ep/jp grade.


Related News: The European Medicines Agency did not say how many shots were affected, but Reuters has reported it involves millions of doses, making it harder for J&J to meet a target of delivering 55 million to Europe by end of June. 3-hydroxytirucallic acid manufacturer Fate Therapeutics has exclusively licensed from MSK foundational intellectual property covering the production and composition of iPSC-derived T cells. 3-hydroxytirucallic acid supplier Biogen last month revived its plans to seek U.S. approval for its aducanumab treatment after announcing in March that it would terminate two large clinical trials for the drug. But some analysts believed FDA approval is highly unlikely. 3-hydroxytirucallic acid vendor Fate Therapeutics has exclusively licensed from MSK foundational intellectual property covering the production and composition of iPSC-derived T cells. 3-hydroxytirucallic acid factory Singapore, Australia, New Zealand, and the United States have banned all foreign nationals traveling from China from entering the country.